Skip to content

Additional Charges Against Springfield, Kirbyville Men Indicted for K2 Conspiracy

SPRINGFIELD – Tammy Dickinson, United States Attorney for the Western District of Missouri, announced last week that a Springfield man and two Kirbyville men have been indicted by a federal grand jury for their roles in a conspiracy to distribute synthetic marijuana, commonly referred to as K2.

Travis E. Butchee, also known as “Donkey,” 37, of Springfield, and Michael J. Saguto, 42, and Christian L. Turner, 45, both of Kirbyville, were charged in a six-count indictment returned by a federal grand jury in Springfield on Wednesday, June 12. The indict­ment replaces a federal criminal complaint that was filed against Butchee and Saguto on May 17, adding Turner as a co-defendant and additional charges.

Butchee opened The Man Cave, a retail business at 1927 S. Glenstone in Springfield, in Febru­ary 2013. Butchee and Saguto are the owners of Southern Spice, LLC and Saguto is the owner of Blues Away, a head shop and novelty store in Memphis, Tenn. Turner was employed by Saguto at Blues Away.

The federal indictment alleges that Butchee, Saguto and Turner participated in a mail fraud conspiracy from March 1, 2011 to May 16, 2013. They allegedly devised a scheme to defraud the Food and Drug Administration and to defraud the public in order to profit from false claims that synthetic marijuana products (such as Blazed, Red Eyed, Donkey Punch, Jolly Grape Giant, South of the Tracks, Baby Face, Scarface, Hillbilly Hay and others) – which were mailed or delivered by commer­cial carriers – were “incense” or “potpourri” and “not for human consumption.” In reality, the indictment says, these substances were synthetic canna­binoids that contained controlled substances and were intended for human consumption as a drug.

The indictment also alleges that Butchee, Saguto and Turner partici­pated in a conspiracy to distribute a controlled substance. They alleg­edly manufactured and distributed synthetic cannabinoids using ingredients obtained through the mail from China and Thailand.

Butchee and Saguto are also charged with three counts of maintaining a place for the purpose of unlawfully storing and distrib­uting a controlled substance. They allegedly used residences in Kir­byville, Merriam Woods and Springfield to store and distribute synthetic marijuana.

Turner is also charged with being a felon in possession of firearms. Turner, having been convicted of a felony, allegedly possessed a Ruger .22-caliber rifle, a Marlin 30-30 caliber rifle, a Rossi .243-caliber rifle with an interchange­able 20-gauge barrel, a Remington 12-gauge shotgun and a Remington .270-caliber rifle.


The indictment also contains a forfeiture allegation, which would require Butchee, Saguto and Turner to forfeit to the government any property obtained from the proceeds of the alleged mail fraud and drug-trafficking conspiracies, including a money judgment of $280,490 as well as $31,580 that was seized by law enforcement officers, a Hummer H2 and several firearms.

According to an affidavit filed in support of the original criminal complaint, Southern Spice manufac­tured synthetic canna­binoids under various labels, which was distributed to several busi­nesses for resale. Search warrants were executed from January to December 2012 at several businesses – including Doobies (at two Springfield locations), Zak’s Place in Springfield, Beer and Bottle liquor store in Hollister, and Big E’s in Lebanon, Mo. – at which law enforcement officers seized hundreds of packages of K2 manu­factured by Southern Spice, which were being sold by the businesses.

According to the affidavit, a total of $169,859 in checks from various head shops, tattoo parlors and other businesses were deposited into the Southern Spice bank account between April 10 and Nov. 20, 2012. Money was wired by Southern Spice to accounts in Hong Kong and China. An analysis of transactions from this bank account, the affidavit says, also showed purchases of other herbal products that are typically used as the plant ingredient in K2.

The affidavit cites four under­cover purchases of K2 from The Man Cave by law enforcement officers in April and May 2013.

On May 16, 2013 law enforce­ment officers executed search warrants at the residences of Saguto and Butchee, as well as at a Merriam Woods residence owned by Butchee. At Saguto’s residence, officers seized the components of a synthetic cannabinoid manufactur­ing laboratory and a significant amount of cash contained in an ammo box. At the Merriam Woods residence, officers seized three five-gallon buckets containing a plant substance identified as synthetic cannabinoids as well as packages filled with a substance believed to be synthetic cannabinoids, which were labeled Hillbilly Hay.

Dickinson cautioned that the charges contained in this indictment are simply accusations, and not evidence of guilt. Evidence supporting the charges must be presented to a federal trial jury, whose duty is to determine guilt or innocence.

This case is being prosecuted by Supervisory Assistant U.S. Attorney Michael S. Oliver. It was investigated by the U.S. Postal Inspection Service, IRS-Criminal Investigation, the Missouri State Highway Patrol, COMET (Combined Ozarks Multi-jurisdictional Enforcement Team) and the Springfield Police Department.

Synthetic Designer Drugs

Over the past several years, smokable herbal blends marketed as being “legal” and providing a marijuana-like high have become increasingly popular, particularly among teens and young adults, because they are easily available and, in many cases, they are more potent and dangerous than marijuana. These products consist of plant material that has been coated with dangerous psychoac­tive compounds that mimic THC, the active ingredient in marijuana. These synthetic cannabinoids are sold at a variety of retail outlets, in head shops and over the Internet. Brands such as K2, Spice, Blaze, and Red X Dawn are labeled as incense to mask their intended purpose. However, they have not been approved by the Food and Drug Administration (FDA) for human consumption or for medical use, and there is no oversight of the manufacturing process.

While many of the designer drugs being marketed today are not specifically prohibited in the Con­trolled Substances Act, the Con­trolled Substance Analogue Enforce­ment Act allows these drugs to be treated as controlled substances if they are proven to be chemically and/or pharmacologi­cally similar to a Schedule I or Schedule II controlled sub­stance.  This analogue provision specifically exists to combat these new and emerging designer drugs.